Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000493595 | SCV000582452 | likely pathogenic | not provided | 2021-10-01 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (Lek et al., 2016); Missense variants in this gene are often considered pathogenic (Stenson et al., 2014); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Labcorp Genetics |
RCV000493595 | SCV002272341 | uncertain significance | not provided | 2021-07-08 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 429796). This variant has not been reported in the literature in individuals affected with GCK-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces leucine with proline at codon 45 of the GCK protein (p.Leu45Pro). The leucine residue is highly conserved and there is a moderate physicochemical difference between leucine and proline. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Clinical Genomics, |
RCV002465692 | SCV002605384 | likely risk allele | Maturity onset diabetes mellitus in young | criteria provided, single submitter | research | Potent mutations in GCK gene is associated with poor secretion of insulin. Its associated with milder forms of diabetes, which can be controlled by diet . However, there is no sufficient evidence to ascertain the significance of rs1131691598 in MODY, yet. | |
Ce |
RCV000493595 | SCV004810533 | uncertain significance | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | GCK: PM2, PP2, PS4:Supporting |